Emergent Biosolutions
EBS7.4102.63% ( +0.190 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Emergent Biosolutions(EBS) predict that the Revenue is 156.1 M (-29.75%), Beat estimate;the EBIT is 10.5 M (-78.96%), Beat estimate;the EPS is 0.07 (-94.12%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.16B29.75%
0.14B34.74%
+0.01B4.99%
EBITExceed expectations
0.01B78.96%
-0.01B117.43%
+0.02B38.47%
EPSExceed expectations
0.0794.12%
-0.38131.93%
+0.450037.81%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 5, 2026
Estimate Revenue177.5 M
Estimate EBIT11 M
Estimate EPS-0.345
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf